πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

30 results for β€œoxytocin” Clear

  1. 1. Intranasal oxytocin spray

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 2 small molecule active

    1 trial

  2. Intranasal Oxytocin

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 2 small molecule completed

    1 trial

  3. Oxytocin

    United Therapeutics Europe Ltd

    Alcohol Use Disorder

    phase 2 small molecule completed

    1 trial

  4. Oxytocin

    BRIGHT MINDS BIOSCIENCES INC.

    Social Cognition

    phase 2 small molecule completed

    1 trial

  5. Oxytocin nasal spray

    COGNITION THERAPEUTICS INC

    Oxidative Stress

    phase 2 small molecule completed

    1 trial

  6. Oxytocin nasal spray

    COGNITION THERAPEUTICS INC

    Cold Exposure

    phase 2 small molecule completed

    1 trial

  7. SYNTOCINON 40 i.e./ml prΕ‘ilo za nos, raztopina, Oxytocin Placebo

    Institut fΓΌr biomedizinische Analytik NMR-Imaging GmbH

    schizophrenia or other primary psychotic disorders (SSD)

    phase 2 small molecule active

    1 trial

  8. Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor

    Tonix Pharmaceuticals Holding

    Pain, Face

    phase 1 small molecule completed

    1 trial

  9. Intranasal Oxytocin (IN-OXT)

    Tonix Pharmaceuticals Holding

    Vasopressin Deficiency

    phase 1 small molecule active

    1 trial

  10. Oxytocin

    United Therapeutics Europe Ltd

    Unit Cohesion

    phase 1 small molecule completed

    1 trial

  11. Oxytocin

    China SXT Pharmaceuticals

    Oxytocin Effect on Memory Performance During Phase 1

    phase 1 small molecule completed

    1 trial

  12. Oxytocin lower does (24IU)

    China SXT Pharmaceuticals

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  13. Oxytocin lower dose (24IU)

    China SXT Pharmaceuticals

    Healhty

    phase 1 small molecule active

    1 trial

  14. Oxytocin nasal spray

    China SXT Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial

  15. Oxytocine and migraine

    Disc Medicine

    This is a study in healthy volunteers. We will study the trigeminovascular system, which is relevant in the pathophysiology of migraine.

    phase 1 other active

    1 trial

  16. oxytocin

    China SXT Pharmaceuticals

    Healthy

    phase 1 small molecule active

    6 trials

  17. PROPESS 10 mg, système de diffusion vaginal, PROSTINE E2 2 mg/3 g, gel vaginal, ANGUSTA 25 microgrammes, comprime, OXYTOCINE PANPHARMA 5 UI/1 ml, solution injectable

    Tour Hekla

    Labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening

    approved small molecule active

    1 trial

  18. Intranasal Oxytocin (OT) 24 IU

    China SXT Pharmaceuticals

    Healthy Participants

    small molecule active

    1 trial

  19. Oral Oxytocin

    China SXT Pharmaceuticals

    Healthy

    small molecule active

    2 trials

  20. Oxytocin

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial

  21. Oxytocin

    China SXT Pharmaceuticals

    Mental Health Wellness 1

    small molecule active

    1 trial

  22. Oxytocin

    United Therapeutics Europe Ltd

    Posttraumatic Stress Disorder

    small molecule completed

    1 trial

  23. Oxytocin

    China SXT Pharmaceuticals

    Postpartum Hemorrhage

    small molecule completed

    1 trial

  24. Oxytocin

    China SXT Pharmaceuticals

    Social Behavior

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources